Cardiac Amyloidosis: Is it a Zebra or a Horse?

Target Audience
This activity is designed to meet the educational needs of the cardiology and oncology healthcare teams who treat patients with cardiac amyloidosis, including physicians (cardiologists and hematologists/oncologists) and advance practice providers (nurse practitioners and PAs).

Program Overview
This activity will educate learners about cardiac amyloidosis and the importance of early multidisciplinary diagnosis and management so patients can have the best possible outcomes.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Diagnose cardiac amyloidosis in a timely fashion
Describe current and emerging therapies to manage cardiac amyloidosis
Develop an effective treatment strategy to manage cardiac amyloidosis
Explain the impact of cardiac amyloidosis heterogeneity on the need for multidisciplinary diagnosis + management